In a meta-analysis of 12 neoadjuvant trials (3119 patients) in muscle-invasive bladder cancer, pathological complete response at cystectomy did not meet trial-level surrogacy criteria for overall survival (R² 0.30 arm-level; 0.06 across 8 RCTs for treatment effects).
Meta-analysisn = 3,119
Scilipoti et al. Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials